NCT01529086View on ClinicalTrials.gov

For Cause Prostate Biopsy in REDUCE Population Trial

CompletedOBSERVATIONAL
Enrollment

6,608

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Prostate Cancer
Trial Locations (1)

44195

Cleveland Clinic, Cleveland

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

The Cleveland Clinic

OTHER

NCT01529086 - For Cause Prostate Biopsy in REDUCE Population Trial | Biotech Hunter | Biotech Hunter